Rgenta Therapeutics
Cambridge, US · Founded 2019 · Delaware corporation · 4 known investors
Founders & leadership
JL
Judith LiDirector
HL
Hongbo LuDirector
DR
Debasish RoychowdhuryDirector
TW
Travis WagerExecutive Officer
SL
Sun LinghaoDirector
HS
Hualin Simon XiExecutive Officer, Director
ZW
Zhiping WengDirector
MH
Martin HeideckerDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$8.9MraisedFeb 2022 · 6 investors · OtherRule 506(b)
▶$8.9MraisedFeb 2022 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Judith LiDirector
- Sun LinghaoDirector
- Hualin Simon XiExecutive Officer, Director
- Fei ShenDirector
- Debasish RoychowdhuryDirector
- Hongbo LuDirector
- Travis WagerExecutive Officer
- Zhiping WengDirector
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$10MraisedMar 2021 · 6 investors · OtherRule 506(b)
▶$10MraisedMar 2021 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Judith LiDirector
- Hongbo LuDirector
- Debasish RoychowdhuryDirector
- Travis WagerExecutive Officer
- Sun LinghaoDirector
- Hualin Simon XiExecutive Officer, Director
- Zhiping WengDirector
- Martin HeideckerDirector
- Offering amount
- $38M
- Amount sold
- $10M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.